MARSHALL WACE, LLP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$11,614,714
-8.0%
108,326
+4.7%
0.02%
-10.7%
Q4 2022$12,631,417
-52.7%
103,426
-60.0%
0.03%
-52.5%
Q3 2022$26,731,000
+331.0%
258,875
+288.0%
0.06%
+353.8%
Q2 2022$6,202,000
-68.9%
66,716
-60.7%
0.01%
-65.8%
Q1 2022$19,941,000
-42.6%
169,911
-34.2%
0.04%
-40.6%
Q4 2021$34,718,000
+1517.8%
258,070
+1816.6%
0.06%
+611.1%
Q3 2021$2,146,000
-10.3%
13,465
-36.6%
0.01%
-62.5%
Q1 2020$2,393,000
+789.6%
21,246
+998.0%
0.02%
+1100.0%
Q4 2019$269,000
+2.3%
1,935
-29.3%
0.00%0.0%
Q3 2019$263,000
-96.1%
2,737
-95.3%
0.00%
-93.8%
Q1 2019$6,814,000
+503.5%
57,896
+221.2%
0.03%
+166.7%
Q4 2018$1,129,000
+27.7%
18,027
+44.5%
0.01%
+200.0%
Q3 2018$884,000
+13.0%
12,476
+6.1%
0.00%
-66.7%
Q2 2018$782,000
-2.1%
11,758
-3.8%
0.01%
-63.6%
Q1 2018$799,000
-54.9%
12,218
-86.0%
0.03%
+175.0%
Q4 2016$1,772,00087,5580.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2022
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders